Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy AngioDynamics stock | 12.51

Own AngioDynamics stock in just a few minutes.

Posted

Fact checked

AngioDynamics, Inc is a medical instruments & supplies business based in the US. AngioDynamics shares (ANGO) are listed on the NASDAQ and all prices are listed in US Dollars. AngioDynamics employs 800 staff and has a trailing 12-month revenue of around USD$268.3 million.

How to buy shares in AngioDynamics

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for AngioDynamics. Find the stock by name or ticker symbol: ANGO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until AngioDynamics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$12.51, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of AngioDynamics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of AngioDynamics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted AngioDynamics's share price?

Since the stock market crash in March caused by coronavirus, AngioDynamics's share price has had significant positive movement.

Its last market close was USD$12.51, which is 0.32% up on its pre-crash value of USD$12.47 and 67.25% up on the lowest point reached during the March crash when the shares fell as low as USD$7.48.

If you had bought USD$1,000 worth of AngioDynamics shares at the start of February 2020, those shares would have been worth USD$638.28 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$910.48.

AngioDynamics share price

Use our graph to track the performance of ANGO stocks over time.

AngioDynamics shares at a glance

Information last updated 2020-10-19.
Latest market close USD$12.51
52-week range USD$7.48 - USD$17.2399
50-day moving average USD$10.4224
200-day moving average USD$10.0419
Wall St. target price USD$14
PE ratio 7.0952
Dividend yield N/A (0%)
Earnings per share (TTM) USD$1.291

Buy AngioDynamics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AngioDynamics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AngioDynamics price performance over time

Historical closes compared with the close of $12.51 from 2020-11-16

1 week (2020-11-23) -0.08%
1 month (2020-10-30) 20.99%
3 months (2020-08-28) 34.23%
6 months (2020-05-29) 22.53%
1 year (2019-11-29) -18.61%
2 years (2018-11-30) -41.79%
3 years (2017-11-30) -27.18%
5 years (2015-11-30) 5.13%

Is AngioDynamics under- or over-valued?

Valuing AngioDynamics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AngioDynamics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

AngioDynamics's P/E ratio

AngioDynamics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, AngioDynamics shares trade at around 7x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

AngioDynamics's PEG ratio

AngioDynamics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.87. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into AngioDynamics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

AngioDynamics's EBITDA

AngioDynamics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$6.5 million.

The EBITDA is a measure of a AngioDynamics's overall financial performance and is widely used to measure a its profitability.

AngioDynamics financials

Revenue TTM USD$268.3 million
Gross profit TTM USD$150.3 million
Return on assets TTM -1.84%
Return on equity TTM -31.76%
Profit margin -63.27%
Book value $11.874
Market capitalisation USD$427 million

TTM: trailing 12 months

Shorting AngioDynamics shares

There are currently 876,620 AngioDynamics shares held short by investors – that's known as AngioDynamics's "short interest". This figure is 3.1% up from 849,904 last month.

There are a few different ways that this level of interest in shorting AngioDynamics shares can be evaluated.

AngioDynamics's "short interest ratio" (SIR)

AngioDynamics's "short interest ratio" (SIR) is the quantity of AngioDynamics shares currently shorted divided by the average quantity of AngioDynamics shares traded daily (recently around 339775.19379845). AngioDynamics's SIR currently stands at 2.58. In other words for every 100,000 AngioDynamics shares traded daily on the market, roughly 2580 shares are currently held short.

However AngioDynamics's short interest can also be evaluated against the total number of AngioDynamics shares, or, against the total number of tradable AngioDynamics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AngioDynamics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 AngioDynamics shares in existence, roughly 20 shares are currently held short) or 0.0327% of the tradable shares (for every 100,000 tradable AngioDynamics shares, roughly 33 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AngioDynamics.

Find out more about how you can short AngioDynamics stock.

AngioDynamics share dividends

We're not expecting AngioDynamics to pay a dividend over the next 12 months.

AngioDynamics share price volatility

Over the last 12 months, AngioDynamics's shares have ranged in value from as little as $7.48 up to $17.2399. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AngioDynamics's is 0.4992. This would suggest that AngioDynamics's shares are less volatile than average (for this exchange).

AngioDynamics overview

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides vascular interventions and therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site